CD34 and acute myeloid leukemia: Recently, researchers from the Perugia team have reported outcomes of haploidentical transplantation in 28 patients with hematologic malignancies (AML = 22, ALL = 5, NHL = 1) who received CD34+ selected grafts and Tregs of infusion [58].